Logo image of EPRX

EUPRAXIA PHARMACEUTICALS INC (EPRX) Stock Analyst Ratings

USA - NASDAQ:EPRX - CA29842P1053 - Common Stock

5.9 USD
+0.15 (+2.61%)
Last: 9/30/2025, 5:20:02 PM
5.83 USD
-0.07 (-1.19%)
After Hours: 9/30/2025, 5:20:02 PM
Buy % Consensus

84

ChartMill assigns a Buy % Consensus number of 84% to EPRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 8.11. This target is 37.41% above the current price.
EPRX was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about EPRX.
In the previous month the buy percentage consensus was at a similar level.
EPRX was analyzed by 9 analysts. More opinions would make the average more meaningful.

Related screens

EPRX Historical Analyst RatingsEPRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -28 -25 -22 -19 -16 -13 -10 -7 -4 -1 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 5.906.578.848.119.10 - 11.33% 49.91% 37.41% 54.32%

Related screens

EPRX Current Analyst RatingEPRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4
Up and Down Grades
Date Firm Action Rating
2025-08-20 HC Wainwright & Co. Reiterate Buy -> Buy
2025-07-24 Cantor Fitzgerald Initiate Overweight
2025-06-26 HC Wainwright & Co. Initiate Buy
2024-11-14 Rodman & Renshaw Initiate Buy